Applying Flow Virometry to Study the HIV Envelope Glycoprotein and Differences Across HIV Model Systems

Viruses. 2024 Jun 9;16(6):935. doi: 10.3390/v16060935.

Abstract

The HIV envelope glycoprotein (Env) is a trimeric protein that facilitates viral binding and fusion with target cells. As the sole viral protein on the HIV surface, Env is important both for immune responses to HIV and in vaccine designs. Targeting Env in clinical applications is challenging due to its heavy glycosylation, high genetic variability, conformational camouflage, and its low abundance on virions. Thus, there is a critical need to better understand this protein. Flow virometry (FV) is a useful methodology for phenotyping the virion surface in a high-throughput, single virion manner. To demonstrate the utility of FV to characterize Env, we stained HIV virions with a panel of 85 monoclonal antibodies targeting different regions of Env. A broad range of antibodies yielded robust staining of Env, with V3 antibodies showing the highest quantitative staining. A subset of antibodies tested in parallel on viruses produced in CD4+ T cell lines, HEK293T cells, and primary cells showed that the cellular model of virus production can impact Env detection. Finally, in addition to being able to highlight Env heterogeneity on virions, we show FV can sensitively detect differences in Env conformation when soluble CD4 is added to virions before staining.

Keywords: Env conformation; HIV Env; HIV trimer; calibrated flow virometry; gp120/gp41; human immunodeficiency virus (HIV); molecules of equivalent soluble fluorophore (MESF); nanoscale flow cytometry; neutralization; virion capture.

MeSH terms

  • Antibodies, Monoclonal / immunology
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / virology
  • HEK293 Cells
  • HIV Antibodies / immunology
  • HIV Infections / virology
  • HIV-1* / genetics
  • HIV-1* / immunology
  • HIV-1* / physiology
  • Humans
  • Virion* / metabolism
  • env Gene Products, Human Immunodeficiency Virus* / chemistry
  • env Gene Products, Human Immunodeficiency Virus* / genetics
  • env Gene Products, Human Immunodeficiency Virus* / immunology
  • env Gene Products, Human Immunodeficiency Virus* / metabolism

Substances

  • env Gene Products, Human Immunodeficiency Virus
  • HIV Antibodies
  • Antibodies, Monoclonal

Grants and funding

This work was supported by grants to CG by the Canadian Institutes of Health Research (CIHR; PJH 175379, PSS 185719, PSS 501566) and the Natural Sciences and Engineering Research Council of Canada (NSERC; RGPIN-2019-06442). A.T.P., and J.B were each supported by an NSERC Canada Graduate Scholarship-Doctoral (CGS-D) award, and C.F with an NSERC CGS-Masters award. JB was also supported through the CIHR Michael Smith Foreign Study Supplement and the Mitacs Globalink Research Award.